The serine protease inhibitor superfamily (serpin) comprises a class of structurally related proteins that include many of the protease inhibitors found in blood, as well as proteins with unrelated or unknown functions. Serpins are involved in the regulation of such diverse processes as coagulation, fibrinolysis, complement activation, ovulation, angiogenesis, inflammation, neoplasia and viral pathogenicity. The serpins act as so-called """"""""suicide inhibitors,"""""""" reacting only once with their target proteinase to form a covalent complex. Serpins also interact with a number of nonproteinase ligands and these interactions can regulate serpin function either by directly modulating inhibitor activity or by restricting their action to a localized compartment. This proposal will focus on two closely related serpins, plasminogen activator inhibitor-I (PAI-1) and neuroserpin as models to investigate serpin function. We will build on extensive previous studies of PAI-1 and neuroserpin and use a combination of biochemical, structural and molecular approaches to address the structural basis of several important serpin interactions. We will identify, express and characterize specific mutations in vitro, and these will be used to map distinct structural regions of PAI-1 important for different functions, including inhibitory specificity. Specific hypotheses regarding the nature of the serpin inhibitory mechanism will also be tested. Methods will also be developed to obtain real time structural information and solution-phase protein dynamics of the serpin structure. These will include site-specific labeling and nuclear magnetic resonance (NMR) and site-specific excimer fluorescence. The interaction of PAl- 1 with members of the lipoprotein receptor family of clearance receptors will also be examined. Current methods of genetic selection will be refined to screen large numbers of PM-i clones for mutants with single functions specifically effected such as binding to the clearance receptors or with unique target proteinase specificity. Together, these studies should help to delineate many important PAI-1 functions and provide a better understanding of serpin function in general in both health and disease.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
2R01HL055747-06
Application #
6542921
Study Section
Hematology Subcommittee 2 (HEM)
Program Officer
Link, Rebecca P
Project Start
1997-07-01
Project End
2007-06-30
Budget Start
2002-07-01
Budget End
2003-06-30
Support Year
6
Fiscal Year
2002
Total Cost
$231,300
Indirect Cost
Name
American National Red Cross
Department
Type
DUNS #
003255213
City
Washington
State
DC
Country
United States
Zip Code
20006
Li, Shih-Hon; Gorlatova, Natalia V; Lawrence, Daniel A et al. (2008) Structural differences between active forms of plasminogen activator inhibitor type 1 revealed by conformationally sensitive ligands. J Biol Chem 283:18147-57
Su, Enming J; Fredriksson, Linda; Geyer, Melissa et al. (2008) Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke. Nat Med 14:731-7
Polavarapu, Rohini; Gongora, Maria Carolina; Yi, Hong et al. (2007) Tissue-type plasminogen activator-mediated shedding of astrocytic low-density lipoprotein receptor-related protein increases the permeability of the neurovascular unit. Blood 109:3270-8
Stefansson, Steingrimur; Su, Enming J; Ishigami, Shoji et al. (2007) The contributions of integrin affinity and integrin-cytoskeletal engagement in endothelial and smooth muscle cell adhesion to vitronectin. J Biol Chem 282:15679-89
Gorlatova, Natalia V; Cale, Jacqueline M; Elokdah, Hassan et al. (2007) Mechanism of inactivation of plasminogen activator inhibitor-1 by a small molecule inhibitor. J Biol Chem 282:9288-96
Ishigami, Shoji; Sandkvist, Maria; Tsui, Foon et al. (2007) Identification of a novel targeting sequence for regulated secretion in the serine protease inhibitor neuroserpin. Biochem J 402:25-34
Yepes, Manuel; Brown, Sharron A N; Moore, Elizabeth G et al. (2005) A soluble Fn14-Fc decoy receptor reduces infarct volume in a murine model of cerebral ischemia. Am J Pathol 166:511-20
Yepes, Manuel; Lawrence, Daniel A (2004) Neuroserpin: a selective inhibitor of tissue-type plasminogen activator in the central nervous system. Thromb Haemost 91:457-64
Stefansson, Steingrimur; Yepes, Manuel; Gorlatova, Natalia et al. (2004) Mutants of plasminogen activator inhibitor-1 designed to inhibit neutrophil elastase and cathepsin G are more effective in vivo than their endogenous inhibitors. J Biol Chem 279:29981-7
Yepes, Manuel; Lawrence, Daniel A (2004) New functions for an old enzyme: nonhemostatic roles for tissue-type plasminogen activator in the central nervous system. Exp Biol Med (Maywood) 229:1097-104

Showing the most recent 10 out of 26 publications